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Vascular anomalies comprise a widely heterogeneous group of tumours and malformations. Haemangioma is the most common
benign tumour of vascular origin of the head and neck region. The possible sites of occurrence in oral cavity are lips, tongue,
buccal mucosa, and palate. Despite its benign origin and behaviour, it is always of clinical importance to the dental profession
and requires appropriate management. This case study reports a rare case of capillary haemangioma on the palatal gingiva in a
14-year-old female.
1.Introduction
Haemangioma are the most common benign vasoformative
tumours of infancy and childhood [1, 2]. They usually are
manifested within the ﬁrst month of life, exhibit a rapid
proliferative phase, and slowly involute to near complete
resolution. There are many ways to classify haemangiomas.
AccordingtoEnzingerandWeiss,haemangiomasarebroadly
classiﬁed into capillary, cavernous, and miscellaneous forms
like verrucous, venous, arteriovenous haemangiomas, and so
forth [3]. Capillary haemangiomas further include juvenile,
pyogenic granuloma, and epitheliod haemangioma [3]. The
term haemangioma has been commonly misused to describe
a large number of vasoformative tumours [4]. However, the
International Society for the Study of Vascular Anomalies
(ISSVA) has recently provided guidelines to diﬀerentiate
these two conditions, according to the novel classiﬁcation
ﬁrst published by Mulliken et al. in 1982 [5]. Vasoformative
tumours are broadly classiﬁed into two groups: haeman-
gioma and vascular malformation [5]. Haemangioma is
histologically further classiﬁed into capillary and cavernous
forms [6, 7]. Capillary haemangioma is composed of many
small capillaries lines by a single layer of endothelial cells
supported in a connective tissue stroma of varying density,
while cavernous haemangioma is formed by large, thin
walled vessels, or sinusoids lined by epithelial cells separated
by thin layer of connective tissue septa [8].
Themajorityofhaemangiomainvolvetheheadandneck.
However, they are rare in the oral cavity but may occur
on tongue, lips, buccal mucosa, gingiva, palatal mucosa,
salivary glands, alveolar ridge, and jaw bones [3, 4, 6, 9–
12]. Clinically, haemangioma appears as soft mass, smooth
orlobulated,andsessileorpedunculatedandmayvaryinsize
from a few mms to several cms [8]. They are usually deep red
and may blanch on the application of pressure and if large
in size, might interfere with mastication [9]. In the present
case study, we report a rare and an unusual case of capillary
haemangioma of the palatal mucosa.
2.CaseReport
A female patient aged 14 years, reported with a chief
complaint of a swelling and growth on the inner side of her
upper front teeth since 4-5 months. She also complains of
localized bleeding in that area on brushing, and there was
slight pain and discomfort on eating.
Dental history revealed that she had a history of gingival
enlargement, one year back, which she had got excised.
However, the growth recurred within two months after
surgical excision. It was initially small in size, gradually2 Case Reports in Medicine
Figure 1: Preoperative intraoral view.
increased and stabilized after 3-4 weeks till the present size.
On general physical examination, it was found that the
patient was normally built for her age with no defect in gait
or stature, and there was no relevant medical history. Family
history was also noncontributory.
A comprehensive intraoral examination revealed a local-
ized gingival mass between maxillary right central incisor
and lateral incisor (11, 12) on the palatal aspect (Figure 1).
It was ﬁrm, pedunculated with a distinct stalk arising from
the interdental papillary region. The mass was bright red,
erythematous and bilobulated with well-deﬁned margins.
Thetwodistinctlobesmeasuredabout5cm ×4cmand3cm
× 2.5cm in diameter. They were ﬁrm and rubbery in texture.
No surface ulceration or secondary infection was noted.
Periodontal examination revealed no clinical attachment
loss. Panoramic examination conﬁrmed no alveolar bone
loss, and a provisional diagnosis of pyogenic granuloma was
made on the basis of history and clinical features.
The other pathologic entities that were included in the
diﬀerential diagnosis were malignancies, trauma, and or
infection (bacterial, viral, and fungal), enlargement due to
drugs. Complete blood examination, urine analysis, and
an intraoral periapical radiograph with respect to 11, 12
were done. The laboratory investigations of blood and urine
were within normal limits that ruled out any leukemic
enlargement and diabetes mellitus. HIV, HBs, VDRL, and
Mantoux test were negative, ruling out any possibility
of infectious involvement. Radiographically, there was no
evidence of crestal bone loss, and lamina dura was intact
around the roots of both maxillary right central and lateral
incisor. Scaling was carried out under universal precautions,
and later surgical excision of the lesion was done under
local anaesthesia as a part of excisional biopsy. A thread was
tied around the stalk of the pedunculated lesion and was
stretched tightly so as to reduce blood circulation to the
lesion. The growth was then surgically excised along with
the stalk, and thorough curettage of the area was performed.
The excised lesion was stored in 10% formalin and sent
for histopathological examination. Periodontal dressing was
applied on the operated area, and the patient was given
Figure 2: H and E stain section at 10x magniﬁcation showing
numerous blood-ﬁlled capillaries in connective tissue stroma.
Figure 3 :P o s t o p e r a t i v ev i e wa f t e ro n ew e e k .
postoperative instructions. Histopathological examination
revealed stratiﬁed squamous epithelium which showed atro-
phy, and in some areas hyperkeratosis was seen. Beneath
this, many small and large capillaries ﬁlled with blood
were present. These vessels were lined by a single layer
of endothelial cells and were supported by a connective
tissue stroma of varying density with no inﬂammatory
component (Figure 2). On the basis of clinical examination
and histopathology, a diagnosis of capillary haemangioma
was made. The patient was recalled after a week with normal
healing and various plaque control measures were reinforced
(Figure 3). The patient was also reviewed 1, 3, and 6 months
after the biopsy, and there was no recurrence of the lesion.
3. Discussion
The confusing and misleading terminology has led to
inappropriate grouping and classiﬁcation of vasoformative
tumours [4]. The diﬀerentiation between haemangioma and
vascular malformations is made on the basis of clinical
appearance, histopathology, and biological behaviour [4].
Pathogenesis and origin of haemangioma remain incom-
pletely understood. However, various theories have beenCase Reports in Medicine 3
proposed to elucidate the mechanism and pathogenesis of
haemangioma. Aberrant and focal proliferation of endothe-
lial cells results in haemangioma, although the cause behind
this remains unclear [13]. The placental theory of hae-
mangioma origin has been described by North et al. [14],
who studied various histology and molecular markers such
as GLUTI, Lewis Y Antigen, Merosin, CCR6, CD15, IDO,
FC, and gamma Receptor II. Positive staining for GLUTI is
considered highly speciﬁc and diagnostic for haemangioma,
and it is useful for making diﬀerential diagnosis between
haemangioma and other vascular lesions clinically related
to it [13]. More recently, somatic mutational events in gene
involved in angiogenesis are related to haemangioma growth
[4]. Growth factors speciﬁcally involved in angiogenesis
such as VEGF, b-TGF, and IGF are often increased during
the proliferation phases of haemangioma growth [15, 16].
Moreover, it has been noted that during the involution phase
of haemangioma, there is a decrease in angiogenic molecules
(VEGF, PCNA, Type IV collagenase, Lewis V antigen, CD
31), while there is increase in concentration of marker for
apoptosis (T4, TUNNEL, INF, Mast cells, and TGF) [4,
17, 18]. Thus, role of molecular signalling is now clear in
haemangioma development.
A variety of other lesions can resemble haemangioma
in the oral cavity. The diﬀerential diagnosis includes pyo-
genic granuloma, chronic inﬂammatory gingival hyper-
plasia, epulis granulomatosa, telangiectasia, angiosarcoma,
squamous cell carcinoma, and other vascular appearing
l e s i o n so ff a c eo ro r a lc a v i t ys u c ha sS t u r g eW e b e rS y n d r o m e
[9].
In the present case, clinical features resemble that of
pyogenic granuloma. However, the lesion did not show
microscopic appearance of a pyogenic granuloma. It con-
tained blood-ﬁlled capillaries lined by layer of endothelial
cells in a connective tissue stroma without any evidence of
inﬂammation.
Angiosarcoma is a rare malignant tumour of vascular
endothelium, and it resembles haemangioma. However, it
can be diﬀerentiated from it on the basis of histopathologic
ﬁndings as it is characterized by inﬁltrative proliferation of
endothelium-lined blood vessels that form an anastomosing
network. The endothelial cells appear hyperchromatic and
atypical and often tend to pile up within vascular lamina
[8].
Management of haemangioma depends on a variety of
factors, and most true haemangioma requires no inter-
vention. However, 10–20% requires treatment because of
the size, exact location, stages of growth or regenera-
tion, functional compromise, and behaviour. The range
of treatment includes surgery, ﬂash lamp pulsed laser,
intralesional injection of ﬁbrosing agent, interferon alpha-
2b, and electrocoagulation while cryosurgery, compression
and radiation were used in the past [11–13, 19–22]. Each
treatment modality has its own risk and beneﬁts. In the
present case, surgery was carried out on the basis of size and
location. Moreover, the diﬃculty in swallowing was another
factor that was taken in consideration, and surgical approach
was preferred as to remove excess residual ﬁbrofatty and
redundant tissue after involution.
4. Conclusion
Haemangioma is of benign origin and behaviour, but
haemangioma in the oral cavity is of clinical importance. It
often mimics other lesion clinically and requires appropriate
clinical diagnosis and proper management.
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